KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Current Assets (2016 - 2025)

Historic Current Assets for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $48.5 million.

  • Petmed Express' Current Assets fell 2906.72% to $48.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $48.5 million, marking a year-over-year decrease of 2906.72%. This contributed to the annual value of $78.9 million for FY2025, which is 1577.93% down from last year.
  • According to the latest figures from Q4 2025, Petmed Express' Current Assets is $48.5 million, which was down 2906.72% from $59.5 million recorded in Q3 2025.
  • In the past 5 years, Petmed Express' Current Assets ranged from a high of $161.2 million in Q1 2021 and a low of $48.5 million during Q4 2025
  • Over the past 5 years, Petmed Express' median Current Assets value was $100.2 million (recorded in 2023), while the average stood at $106.1 million.
  • In the last 5 years, Petmed Express' Current Assets skyrocketed by 2493.37% in 2021 and then plummeted by 3876.25% in 2023.
  • Petmed Express' Current Assets (Quarter) stood at $142.9 million in 2021, then fell by 6.22% to $134.0 million in 2022, then dropped by 28.7% to $95.5 million in 2023, then dropped by 28.43% to $68.4 million in 2024, then fell by 29.07% to $48.5 million in 2025.
  • Its Current Assets stands at $48.5 million for Q4 2025, versus $59.5 million for Q3 2025 and $67.9 million for Q2 2025.